U.S. markets closed

NanoString Technologies, Inc. (NSTG)

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Add to watchlist
36.65-0.41 (-1.11%)
At close: 4:00PM EDT
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Commodity Channel Index

Commodity Channel Index

Previous Close37.06
Open36.81
Bid36.59 x 900
Ask36.59 x 1100
Day's Range36.00 - 37.39
52 Week Range13.85 - 46.93
Volume450,777
Avg. Volume568,410
Market Cap1.603B
Beta (5Y Monthly)1.35
PE Ratio (TTM)N/A
EPS (TTM)-1.76
Earnings DateNov 09, 2020
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est45.00
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
Overvalued
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
View more
  • NanoString Technologies Announces Closing of Public Offering of $230.0 Million of Common Stock Including Exercise in Full of Option to Purchase Additional Shares
    Business Wire

    NanoString Technologies Announces Closing of Public Offering of $230.0 Million of Common Stock Including Exercise in Full of Option to Purchase Additional Shares

    NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for discovery and translational research, today announced the closing of its previously announced underwritten public offering of 5,750,000 shares of its common stock at a price to the public of $40.00 per share pursuant to its existing shelf registration statement, for gross proceeds of $230.0 million. The number of shares issued at closing included the exercise in full of the underwriters’ option to purchase 750,000 additional shares. Net proceeds to NanoString from the offering were approximately $215.7 million after deducting underwriting discounts and commissions and the estimated expenses of the offering. NanoString intends to use the net proceeds of the offering for working capital and general corporate purposes.

  • OnRamp Bio and NanoString Announce Global Availability of ROSALIND® for nCounter Users
    Business Wire

    OnRamp Bio and NanoString Announce Global Availability of ROSALIND® for nCounter Users

    NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for discovery and translational research, and OnRamp Bioinformatics, a provider of cloud-based genomic analysis tools, today announced a key milestone in their partnership to develop new analysis tools to accelerate research on NanoString’s nCounter® Analysis System. After successful completion of an Early Access Program announced in May, the parties are expanding access to new analysis capabilities to all nCounter users. The new analysis functionality is built into ROSALIND®, OnRamp’s cloud-based analysis platform that facilitates data visualization, exploration and collaboration. NanoString will support ROSALIND as a preferred analysis solution for nCounter data and make it broadly available to users of the nCounter Analysis System.

  • NanoString Technologies Announces Pricing of Upsized Public Offering of $200 Million of Common Stock
    Business Wire

    NanoString Technologies Announces Pricing of Upsized Public Offering of $200 Million of Common Stock

    NanoString announces pricing of upsized public stock offering.